Expectations trend
FY2028 · fiscal year ending 2028-10-31 · fmp
$15.39 → $15.39 · observed estimates
Keysight Technologies (KEYS)
NYSEInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-05
$260.61-8.83%
Close 2026-11-05 · 1-day change
NYSEInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for KEYS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Non-GAAP EPS near $2.46 in Q3 FY2026 | Profit per share is rising, with EPS near $2.46 next quarter. | Intact | EPS falls below $2.43 in Q3 FY2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-10-31 · fmp
$15.39 → $15.39 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 19, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
KEYS is a growth-oriented technology business, with recent financial performance in the top half of its industry. Its long-term thesis is intact, supported by rising momentum and management execution, though earnings quality is neutral and risk is moderate.
The valuation evidence suggests KEYS is broadly aligned with expectations, with a slight premium to peers and a small negative expectations gap. Model confidence is low, so the exact valuation read is uncertain; there is no evidence of concentrated fragility.
Near-term results have been strong: revenue rose from $1.60 billion in the first quarter of 2026 to $1.85 billion in the third, while non-GAAP earnings per share increased from $2.17 to $3.07. Management’s growth and earnings priorities are on track, but recent earnings surprises have been trending down and a past deep miss remains a caution.
Over the next few quarters, the thesis depends on continued revenue growth and whether management avoids cutting guidance. A guidance cut would be a meaningful negative; lower interest rates or steadier results and guidance from technology peers could support the sector backdrop.
For the next 1 to 3 years, KEYS has a strong operating trajectory and an intact long-term thesis, but the valuation case is not clear-cut and execution remains important. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Keysight Technologies's published investment case. The stated target is Integration completed and contributing to growth by FY26 end. |
| Intact |
| Acquisition fails to contribute to revenue or profit growth by FY26 end |
Qualitative: Integration contributing to growth (Orders >$2B, Raised Outlook) Keysight raised its 2026 outlook and reported orders topping $2B, driven by AI and 6G demand, reinforcing the growth thesis. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth reaching about $1.74 billion in Q3 FY2026 | Keysight grows revenue about 19% a year, hitting $1.74 billion next quarter. | Intact | revenue falls below $1.69B in Q3 FY2026 | Revenue: $1.846B FY2026-Q3; GAAP. Published target: ~$1.74B. Same fiscal period as the stored target. Sep 2, 20261,846,000,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$8.83B → $8.83B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-11-01 | $15.39 | $8,828,066,178 | 2 / 10 |
| 2026-11-02 | $15.39 | $8,828,066,178 | 2 / 10 |
| 2026-11-03 | $15.39 | $8,828,066,178 | 2 / 10 |
| 2026-11-04 | $15.39 | $8,828,066,178 | 3 / 10 |
| 2026-11-05 | $15.39 | $8,828,066,178 | 3 / 10 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 11 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
1 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.